Online inquiry

IVTScrip™ mRNA-Human AK095700, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17743MR)

This product GTTS-WK17743MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AK095700 protein. This product can be used in Plasmacytoid dendritic cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 338799
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AK095700, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17743MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK15045MR IVTScrip™ mRNA-Human AK124399, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AK124399
GTTS-WK17449MR IVTScrip™ mRNA-Human AK307192, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA AK307192
GTTS-WK14484MR IVTScrip™ mRNA-Human AL117190.2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA AL117190.2
GTTS-WK15341MR IVTScrip™ mRNA-Human AK057596, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA AK057596
GTTS-WK19545MR IVTScrip™ mRNA-Human AK124399, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AK124399
GTTS-WK22503MR IVTScrip™ mRNA-Human APCDD1L-AS1, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA APCDD1L-AS1
GTTS-WK20146MR IVTScrip™ mRNA-Human AK125727, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AK125727
GTTS-WK20743MR IVTScrip™ mRNA-Human AK095700, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA AK095700
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →